Dehydrovomifoliol
Product Specifications
UNSPSC Description
Dehydrovomifoliol is a AKT/mTOR dual inhibitor. Dehydrovomifoliol reduces lipid accumulation and lipogenesis by inhibiting the AKT/mTOR signaling pathway. Dehydrovomifoliol is used in nonalcoholic fatty liver disease research (NAFLD) .
Target Antigen
Akt; mTOR
Type
Natural Products
Related Pathways
PI3K/Akt/mTOR
Field of Research
Metabolic Disease
Assay Protocol
https://www.medchemexpress.com/dehydrovomifoliol.html
Smiles
CC(/C=C/[C@](C(C)(C1)C)(C(C)=CC1=O)O)=O
Molecular Weight
222.28
References & Citations
[1]Ma
J, et al. Dehydrovomifoliol Alleviates Nonalcoholic Fatty
Liver Disease via the E2F1/AKT/mTOR Axis: Pharmacophore Modeling and Molecular
Docking Study. Evid Based Complement Alternat Med. 2023 Feb 1;2023:9107598.
Shipping Conditions
Room temperature
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-137996/Dehydrovomifoliol-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-137996/
CAS Number
39763-33-2
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
